Parallax Volatility Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100
Closed -$40.3K 2183
2024
Q4
$40.3K Buy
+100
New +$46.4K ﹤0.01% 1801
2024
Q2
Sell
-24,600
Closed -$10.3M 2284
2024
Q1
$10.3M Buy
24,600
+5,000
+26% +$2.11M 0.02% 500
2023
Q4
$7.98M Buy
19,600
+5,100
+35% +$1.88M 0.02% 654
2023
Q3
$5.04M Buy
14,500
+12,200
+530% +$4.27M 0.01% 760
2023
Q2
$809K Sell
2,300
-500
-18% -$168K ﹤0.01% 1489
2023
Q1
$882K Sell
2,800
-5,800
-67% -$1.74M ﹤0.01% 1551
2022
Q4
$2.48M Sell
8,600
-2,200
-20% -$670K ﹤0.01% 1324
2022
Q3
$3.13M Buy
10,800
+1,600
+17% +$460K ﹤0.01% 1210
2022
Q2
$2.59M Sell
9,200
-61,800
-87% -$16.5M ﹤0.01% 1243
2022
Q1
$18.5M Buy
71,000
+42,700
+151% +$10.1M 0.01% 535
2021
Q4
$6.21M Buy
28,300
+7,800
+38% +$1.52M 0.01% 734
2021
Q3
$3.72M Sell
20,500
-12,100
-37% -$2.36M ﹤0.01% 923
2021
Q2
$6.57M Buy
32,600
+10,600
+48% +$2.22M 0.01% 597
2021
Q1
$4.73M Buy
22,000
+13,700
+165% +$3.01M 0.01% 526
2020
Q4
$1.96M Buy
8,300
+6,600
+388% +$1.51M ﹤0.01% 1254
2020
Q3
$461K Buy
1,700
+500
+42% +$138K ﹤0.01% 2274
2020
Q2
$348K Sell
1,200
-1,900
-61% -$515K ﹤0.01% 2088
2020
Q1
$739K Sell
3,100
-19,000
-86% -$4.36M ﹤0.01% 1585
2019
Q4
$4.84M Buy
22,100
+6,300
+40% +$1.28M 0.01% 921
2019
Q3
$2.68M Buy
15,800
+12,600
+394% +$2.23M ﹤0.01% 1030
2019
Q2
$588K Buy
3,200
+2,800
+700% +$489K ﹤0.01% 1451
2019
Q1
$74K Sell
400
-10,200
-96% -$1.88M ﹤0.01% 2187
2018
Q4
$1.76M Buy
10,600
+100
+1% +$17.3K ﹤0.01% 1103
2018
Q3
$2.02M Buy
10,500
+500
+5% +$89K ﹤0.01% 1019
2018
Q2
$1.7M Buy
+10,000
New +$1.55M ﹤0.01% 956
2017
Q2
Sell
-30,000
Closed -$3.28M 4119
2017
Q1
$3.28M Buy
+30,000
New +$2.64M 0.01% 702
2015
Q4
Sell
-15,000
Closed -$1.56M 4013
2015
Q3
$1.56M Buy
+15,000
New +$1.93M ﹤0.01% 1125

Other funds holding VRTX